Feasibility & Safety of Nintedanib in Combination With Nivolumab in

See also
Status	Clinical Trial	Phase
Completed	`NCT01935336` - Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers	Phase 2
Recruiting	`NCT02239432` - Telomere Biology in Early Adenocarcinoma of the Lung	N/A
Recruiting	`NCT02288026` - Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer	N/A
Completed	`NCT00087412` - S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer	Phase 2
Completed	`NCT00049543` - Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery	Phase 3
Terminated	`NCT01707823` - Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer	Early Phase 1
Completed	`NCT00002852` - Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer	Phase 3
Terminated	`NCT00042835` - Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer	Phase 1
Completed	`NCT00040794` - Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer	Phase 2
Active, not recruiting	`NCT01345851` - Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery	N/A
Withdrawn	`NCT02059967` - Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC	Phase 1
Completed	`NCT00005838` - Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery	Phase 3
Completed	`NCT01218516` - A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung	Phase 2
Terminated	`NCT02715102` - Circulating Tumor DNA in Patients at High Risk for Lung Cancer	N/A
Terminated	`NCT00369551` - Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer	Phase 1
Completed	`NCT00118144` - Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer	Phase 2
Completed	`NCT00020709` - Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery	Phase 3
Withdrawn	`NCT02466568` - Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung	Phase 1/Phase 2
Completed	`NCT01557959` - Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer	Phase 2
Completed	`NCT00118183` - Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer	Phase 2

NCT number	NCT04046614
Study type	Interventional
Source	AIO-Studien-gGmbH
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	May 25, 2018
Completion date	September 15, 2023

Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology — NintNivo

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms